BioSpace News Archive

Free Standing Centers Improve Accessibility to Sophisticated Cancer Care for Local Communities

CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, reports the European Commission’s announcement that tomorrow it will authorize an Advanced Purchase Agreement for CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV.

BIOREM Inc. announced a number of new orders totalling $10.8 million.

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

Tauriga Sciences, Inc. announced that it has extended its relationship with Chinese E-Commerce & Retail giant, Alibaba Group, for a period of an additional 12 months.

The largest HMO in Israel, and second largest in the world, Clalit has worked with Zebra Medical Vision for the past six years, reaching a significant milestone of being the first HMO in the world to begin implementing cloud-based imaging AI in large scale for population health needs

Istari Oncology, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug application (IND) for a Phase 2 clinical trial, LUMINOS-102,

Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, today reported financial results for the three and nine months ended September 30, 2020, and provided a recent business update.

Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced the Company will present and conduct one-on-one meetings with investors at the Piper Sandler 32nd Annual Virtual Healthcare Conference.

Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus Infection Presented at The Liver Meeting Digital Experience™ 2020